Skip to content

Comparative evaluation of 0.5% ropivacaine instillation through subgaleal drain versus skin infiltration for management of post-craniotomy pain

Comparative evaluation of 0.5% ropivacaine instillation through subgaleal drain versus skin infiltration for management of post-craniotomy pain - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063825
Enrollment
60
Registered
2024-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G89-G99- Other disorders of the nervous system

Interventions

Intervention1: Local anaesthetic (0.5% ropivacaine) to be instilled in subgaleal drain: Group A : 12 ml of 0.5% ropivacaine to be instilled in the subgaleal drain at the end of surgery Control Interve

Sponsors

Dayanand Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adult patients aged 18 - 65 years. 2.ASA grade I to grade III 3.Patients posted for elective craniotomy

Exclusion criteria

Exclusion criteria: 1.Patients with ASA grade IV or more 2. Patients with Glasgow coma score(GCS) less than 13 3. Patients allergic to local anaesthetic agents 4. Patients scheduled for aneurysm clipping surgery. 5. Patients with history of opioid use. 6. Patients unable to communicate and comprehend NRS scale. 7. Patients planned for elective post operative ventilatory support. 8. Any patient requiring re-intubation within first 24 hours will also be excluded.

Design outcomes

Primary

MeasureTime frame
Total rescue analgesic consumption in 24 hours.Timepoint: 0,1,2,3,4,8,12,16,20,24 hours

Secondary

MeasureTime frame
Postoperative pain scores assessed by NRS.Timepoint: 0,1,2,3,4,8,12,16,20,24 hours

Countries

India

Contacts

Public ContactDr Pulkit Nagpal

Dayanand Medical College and Hospital Ludhiana

pulkitnagpal1997@gmail.com7696747009

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026